San Diego, CA, United States of America

Colette Dooley


Average Co-Inventor Count = 4.5

ph-index = 1

Forward Citations = 44(Granted Patents)


Company Filing History:


Years Active: 2002-2013

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Colette Dooley: Innovator in Pharmaceutical Sciences

Introduction

Colette Dooley is a prominent inventor based in San Diego, California, known for her significant contributions to the field of pharmaceutical sciences. With three patents to her name, her work focuses on innovative therapeutic techniques and drug development.

Latest Patents

Her most recent patents highlight her cutting-edge research. One patent, titled "Melanin-concentrating hormone receptor antagonists and methods of use," pertains to N-benzylamino cyclic thioureas, which serve as antagonists of the melanin-concentrating hormone receptor (MCH receptor). This discovery holds potential for developing new treatments in various medical applications. Another notable patent, "Combinatorial libraries of bicyclic guanidine derivatives and compounds therein," describes a rapid approach for synthesizing and screening combinatorial libraries of bicyclic guanidine compounds, facilitating drug discovery and development.

Career Highlights

Throughout her career, Colette has worked with several reputable organizations, including Lion Bioscience and Mixture Sciences, Inc. These experiences have allowed her to refine her expertise in drug formulation and development, positioning her as a key contributor in her field.

Collaborations

Colette has collaborated with distinguished colleagues such as Richard Allen Houghten and Beverly E. Girten. Their combined expertise strengthens the impact of their collective research efforts, leading to advancements in pharmaceutical sciences.

Conclusion

Colette Dooley's innovative spirit and dedication to her field have resulted in valuable contributions that continue to shape the landscape of pharmaceutical research. Her patents stand as a testament to her skills and creativity, benefiting both the scientific community and society at large.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…